• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血红素和载脂蛋白加合物的形成导致 17-乙炔基雌二醇对人 CYP2J2 的基于机制的失活。

Formation of Both Heme and Apoprotein Adducts Contributes to the Mechanism-Based Inactivation of Human CYP2J2 by 17-Ethynylestradiol.

机构信息

Department of Pharmacology, University of Michigan, Ann Arbor, Michigan.

Department of Pharmacology, University of Michigan, Ann Arbor, Michigan

出版信息

Drug Metab Dispos. 2018 Jun;46(6):813-822. doi: 10.1124/dmd.118.080903. Epub 2018 Mar 30.

DOI:10.1124/dmd.118.080903
PMID:29602797
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5931439/
Abstract

17-Ethynylestradiol (EE), a major component of many oral contraceptives, affects the activities of a number of the human cytochrome P450 (P450) enzymes. Here, we characterized the effect of EE on CYP2J2, a major human P450 isoform that participates in metabolism of arachidonic acid. EE inactivated the hydroxyebastine carboxylation activity of CYP2J2 in a reconstituted system. The loss of activity is time and concentration dependent and requires NADPH. The and values for the inactivation were 3.6 M and 0.08 minute, respectively. Inactivation of CYP2J2 by EE was due to formation of a heme adduct as well as an apoprotein adduct. Mass spectral analysis of CYP2J2 partially inactivated by EE showed two distinct protein masses in the deconvoluted spectrum that exhibited a mass difference of approximately 312 Da, which is equivalent to the sum of the mass of EE and one oxygen atom. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis revealed a heme adduct with MH ion at / 875.5, corresponding to alkylation of an iron-depleted prosthetic heme by EE plus one oxygen atom. The reactive intermediate responsible for covalently modifying both the prosthetic heme and apoprotein was characterized by trapping with glutathione (GSH). LC-MS/MS analysis revealed two GSH conjugate isomers with MH ions at / 620, which were formed by reaction between GSH and EE with the oxygen being added to either the internal or terminal carbon of the ethynyl moiety. High-pressure liquid chromatography analysis revealed that three other major metabolites were formed during EE metabolism by CYP2J2.

摘要

17-乙炔基雌二醇(EE)是许多口服避孕药的主要成分,它会影响许多人类细胞色素 P450(CYP)酶的活性。在这里,我们研究了 EE 对 CYP2J2 的影响,CYP2J2 是一种主要的人类 P450 同工酶,参与花生四烯酸的代谢。EE 在重组体系中使 CYP2J2 的羟基依巴斯汀羧化活性失活。这种失活作用具有时间和浓度依赖性,需要 NADPH。失活的 和 值分别为 3.6 M 和 0.08 分钟。EE 通过形成血红素加合物和脱辅基蛋白加合物使 CYP2J2 失活。用 EE 部分失活的 CYP2J2 的质谱分析显示,在去卷积图谱中出现了两个明显不同的蛋白质量,其质量差约为 312 Da,相当于 EE 和一个氧原子的质量总和。液相色谱-串联质谱(LC-MS/MS)分析显示 MH 离子为 / 875.5 的血红素加合物,对应于 EE 加一个氧原子对缺铁血红素辅基的烷基化。用谷胱甘肽(GSH)捕获鉴定出导致辅基血红素和脱辅基蛋白共价修饰的反应性中间产物。LC-MS/MS 分析显示,MH 离子为 / 620 的两种 GSH 结合异构体,是由 GSH 与 EE 反应形成的,氧原子分别加到乙炔基的内部或末端碳原子上。高效液相色谱分析显示,CYP2J2 代谢 EE 时还形成了另外三种主要代谢物。

相似文献

1
Formation of Both Heme and Apoprotein Adducts Contributes to the Mechanism-Based Inactivation of Human CYP2J2 by 17-Ethynylestradiol.血红素和载脂蛋白加合物的形成导致 17-乙炔基雌二醇对人 CYP2J2 的基于机制的失活。
Drug Metab Dispos. 2018 Jun;46(6):813-822. doi: 10.1124/dmd.118.080903. Epub 2018 Mar 30.
2
The inactivation of cytochrome P450 3A5 by 17alpha-ethynylestradiol is cytochrome b5-dependent: metabolic activation of the ethynyl moiety leads to the formation of glutathione conjugates, a heme adduct, and covalent binding to the apoprotein.17α-乙炔雌二醇对细胞色素P450 3A5的失活作用依赖于细胞色素b5:乙炔基部分的代谢活化导致谷胱甘肽缀合物、血红素加合物的形成以及与脱辅基蛋白的共价结合。
J Pharmacol Exp Ther. 2007 Apr;321(1):276-87. doi: 10.1124/jpet.106.117861. Epub 2007 Jan 24.
3
Heme Modification Contributes to the Mechanism-Based Inactivation of Human Cytochrome P450 2J2 by Two Terminal Acetylenic Compounds.血红素修饰参与两种末端炔类化合物对人细胞色素P450 2J2基于机制的失活作用。
Drug Metab Dispos. 2017 Sep;45(9):990-999. doi: 10.1124/dmd.117.075846. Epub 2017 Jul 11.
4
Mechanism-based inactivation of cytochrome P450 3A4 by 17 alpha-ethynylestradiol: evidence for heme destruction and covalent binding to protein.17α-乙炔雌二醇对细胞色素P450 3A4的基于机制的失活:血红素破坏及与蛋白质共价结合的证据
J Pharmacol Exp Ther. 2002 Apr;301(1):160-7. doi: 10.1124/jpet.301.1.160.
5
Metabolic activation of mifepristone [RU486; 17beta-hydroxy-11beta-(4-dimethylaminophenyl)-17alpha-(1-propynyl)-estra-4,9-dien-3-one] by mammalian cytochromes P450 and the mechanism-based inactivation of human CYP2B6.米非司酮[RU486;17β-羟基-11β-(4-二甲基氨基苯基)-17α-(1-丙炔基)-雌甾-4,9-二烯-3-酮]由哺乳动物细胞色素P450介导的代谢活化作用以及对人CYP2B6基于机制的失活作用。
J Pharmacol Exp Ther. 2009 Apr;329(1):26-37. doi: 10.1124/jpet.108.148536. Epub 2009 Jan 23.
6
Mechanism-based inactivation of cytochromes P450 2E1 and 2E1 T303A by tert-butyl acetylenes: characterization of reactive intermediate adducts to the heme and apoprotein.叔丁基乙炔基于机制的细胞色素P450 2E1和2E1 T303A失活:血红素和脱辅基蛋白反应性中间体加合物的表征
Chem Res Toxicol. 2002 Dec;15(12):1561-71. doi: 10.1021/tx020052x.
7
Mechanism-based inactivation of CYP2B1 and its F-helix mutant by two tert-butyl acetylenic compounds: covalent modification of prosthetic heme versus apoprotein.两种叔丁基炔类化合物对CYP2B1及其F-螺旋突变体的基于机制的失活作用:辅基血红素与脱辅基蛋白的共价修饰
J Pharmacol Exp Ther. 2009 Nov;331(2):392-403. doi: 10.1124/jpet.109.158782. Epub 2009 Aug 21.
8
Identification of 17-alpha-ethynylestradiol-modified active site peptides and glutathione conjugates formed during metabolism and inactivation of P450s 2B1 and 2B6.鉴定17-α-乙炔基雌二醇修饰的活性位点肽以及在细胞色素P450 2B1和2B6代谢及失活过程中形成的谷胱甘肽缀合物。
Chem Res Toxicol. 2006 Feb;19(2):279-87. doi: 10.1021/tx050256o.
9
The effect of ritonavir on human CYP2B6 catalytic activity: heme modification contributes to the mechanism-based inactivation of CYP2B6 and CYP3A4 by ritonavir.利托那韦对人 CYP2B6 催化活性的影响:血红素修饰导致利托那韦对 CYP2B6 和 CYP3A4 的机制性失活。
Drug Metab Dispos. 2013 Oct;41(10):1813-24. doi: 10.1124/dmd.113.053108. Epub 2013 Jul 25.
10
Mechanism-based inactivation of cytochrome P-450-3A4 by mifepristone (RU486).米非司酮(RU486)对细胞色素P-450-3A4的基于机制的失活作用
J Pharmacol Exp Ther. 1999 Feb;288(2):791-7.

引用本文的文献

1
Construction of a CYP2J2-Template System and Its Application for Ligand Metabolism Prediction.CYP2J2模板系统的构建及其在配体代谢预测中的应用。
Food Saf (Tokyo). 2024 Dec 20;12(4):69-82. doi: 10.14252/foodsafetyfscj.D-24-00010. eCollection 2024 Dec.
2
Inhibition of Cytochrome P450 Enzymes by Drugs-Molecular Basis and Practical Applications.药物对细胞色素P450酶的抑制作用——分子基础与实际应用
Biomol Ther (Seoul). 2022 Jan 1;30(1):1-18. doi: 10.4062/biomolther.2021.102.
3
CYP2J2 Molecular Recognition: A New Axis for Therapeutic Design.CYP2J2 分子识别:治疗设计的新轴心。
Pharmacol Ther. 2020 Nov;215:107601. doi: 10.1016/j.pharmthera.2020.107601. Epub 2020 Jun 11.
4
Time-dependent enzyme inactivation: Numerical analyses of in vitro data and prediction of drug-drug interactions.时间依赖性酶失活:体外数据的数值分析及药物相互作用的预测。
Pharmacol Ther. 2020 Feb;206:107449. doi: 10.1016/j.pharmthera.2019.107449. Epub 2019 Dec 11.
5
Acetylenes: cytochrome P450 oxidation and mechanism-based enzyme inactivation.炔烃:细胞色素 P450 氧化和基于机制的酶失活。
Drug Metab Rev. 2019 May;51(2):162-177. doi: 10.1080/03602532.2019.1632891. Epub 2019 Jul 7.
6
Role of Arginine 117 in Substrate Recognition by Human Cytochrome P450 2J2.精氨酸 117 在人细胞色素 P450 2J2 对底物识别中的作用。
Int J Mol Sci. 2018 Jul 16;19(7):2066. doi: 10.3390/ijms19072066.

本文引用的文献

1
Heme Modification Contributes to the Mechanism-Based Inactivation of Human Cytochrome P450 2J2 by Two Terminal Acetylenic Compounds.血红素修饰参与两种末端炔类化合物对人细胞色素P450 2J2基于机制的失活作用。
Drug Metab Dispos. 2017 Sep;45(9):990-999. doi: 10.1124/dmd.117.075846. Epub 2017 Jul 11.
2
CYP2J2 and CYP2C19 are the major enzymes responsible for metabolism of albendazole and fenbendazole in human liver microsomes and recombinant P450 assay systems.CYP2J2 和 CYP2C19 是人类肝微粒体和重组 P450 测定系统中负责阿苯达唑和芬苯达唑代谢的主要酶。
Antimicrob Agents Chemother. 2013 Nov;57(11):5448-56. doi: 10.1128/AAC.00843-13. Epub 2013 Aug 19.
3
The effect of ritonavir on human CYP2B6 catalytic activity: heme modification contributes to the mechanism-based inactivation of CYP2B6 and CYP3A4 by ritonavir.利托那韦对人 CYP2B6 催化活性的影响:血红素修饰导致利托那韦对 CYP2B6 和 CYP3A4 的机制性失活。
Drug Metab Dispos. 2013 Oct;41(10):1813-24. doi: 10.1124/dmd.113.053108. Epub 2013 Jul 25.
4
Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance.细胞色素 P450 2J2:分布、功能、调节、遗传多态性及临床意义。
Drug Metab Rev. 2013 Aug;45(3):311-52. doi: 10.3109/03602532.2013.806537.
5
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.发现并鉴定新型、有效且选择性的细胞色素 P450 2J2 抑制剂。
Drug Metab Dispos. 2013 Jan;41(1):60-71. doi: 10.1124/dmd.112.048264. Epub 2012 Oct 2.
6
Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.鉴定 CYP2J2 活性评价的选择性底物和抑制剂对。
Drug Metab Dispos. 2012 May;40(5):943-51. doi: 10.1124/dmd.111.043505. Epub 2012 Feb 10.
7
Epoxyeicosatrienoic acids protect rat hearts against tumor necrosis factor-α-induced injury.环氧二十碳三烯酸可保护大鼠心脏免受肿瘤坏死因子-α诱导的损伤。
J Lipid Res. 2012 Mar;53(3):456-466. doi: 10.1194/jlr.M017319. Epub 2012 Jan 5.
8
The roles of cytochrome p450 in ischemic heart disease.细胞色素 p450 在缺血性心脏病中的作用。
Curr Drug Metab. 2011 Jul;12(6):526-32. doi: 10.2174/138920011795713715.
9
Metabolic activity and mRNA levels of human cardiac CYP450s involved in drug metabolism.涉及药物代谢的人心脏 CYP450 代谢酶的代谢活性和 mRNA 水平。
PLoS One. 2010 Dec 14;5(12):e15666. doi: 10.1371/journal.pone.0015666.
10
Inhibition of carcinoma cell motility by epoxyeicosatrienoic acid (EET) antagonists.环氧二十碳三烯酸(EET)拮抗剂抑制癌细胞迁移。
Cancer Sci. 2010 Dec;101(12):2629-36. doi: 10.1111/j.1349-7006.2010.01713.x. Epub 2010 Aug 27.